手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| Somatic Symptom Scale-8 (SSS-8)× | 迅速抑うつ症状評価尺度 (QIDS)× | |
|---|---|---|
| 分野 | 臨床心理学 | 臨床心理学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2014 | 2003 |
| 提唱者≠ | Bernd Gierk | A. John Rush |
| 種類≠ | Self-report questionnaire | Self-report or clinician-administered questionnaire |
| 原典≠ | Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zhan, Y., Scherer, M., & Herzberg, P. Y. (2014). The Somatic Symptom Scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Internal Medicine, 174(3), 399–407. DOI ↗ | Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. DOI ↗ |
| 別名≠ | SSS-8, Somatic Symptom Scale | QIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SR |
| 関連≠ | 3 | 4 |
| 概要≠ | The Somatic Symptom Scale-8 is a brief eight-item self-report instrument designed by Bernd Gierk and colleagues to assess the severity and burden of somatic (bodily) symptoms. Published in JAMA Internal Medicine in 2014, the SSS-8 is derived from the longer Somatic Symptom Disorder-B Criteria Scale and serves as a rapid screening tool for somatic symptom disorder and medically unexplained symptoms. It is widely used in primary care, general medicine, and psychiatry to identify patients whose physical complaints may warrant psychological or behavioral intervention. | The Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials. |
| ScholarGateデータセット ↗ |
|
|